191 related articles for article (PubMed ID: 31941448)
1. Lymphedema in three previously Wuchereria bancrofti-endemic health districts in Mali after cessation of mass drug administration.
Dolo H; Coulibaly YI; Konipo FN; Coulibaly SY; Doumbia SS; Sangare MB; Soumaoro L; Coulibaly ME; Diallo AA; Diarra Y; Sangare M; Doumbia S; Colebunders R; Nutman TB
BMC Infect Dis; 2020 Jan; 20(1):48. PubMed ID: 31941448
[TBL] [Abstract][Full Text] [Related]
2. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
[TBL] [Abstract][Full Text] [Related]
3. Progress on elimination of lymphatic filariasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y
Parasit Vectors; 2018 Jun; 11(1):334. PubMed ID: 29866207
[TBL] [Abstract][Full Text] [Related]
4. Developing the first national database and map of lymphatic filariasis clinical cases in Bangladesh: Another step closer to the elimination goals.
Karim MJ; Haq R; Mableson HE; Sultan Mahmood ASM; Rahman M; Chowdhury SM; Rahman AKMF; Hafiz I; Betts H; Mackenzie C; Taylor MJ; Kelly-Hope LA
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007542. PubMed ID: 31306409
[TBL] [Abstract][Full Text] [Related]
5. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Endeshaw T; Taye A; Tadesse Z; Katabarwa MN; Shafi O; Seid T; Richards FO
Pathog Glob Health; 2015; 109(7):344-51. PubMed ID: 26878935
[TBL] [Abstract][Full Text] [Related]
6. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
[TBL] [Abstract][Full Text] [Related]
7. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
9. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
[TBL] [Abstract][Full Text] [Related]
10. No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds.
Coulibaly YI; Sangare M; Dolo H; Soumaoro L; Coulibaly SY; Dicko I; Diabaté AF; Diarra L; Coulibaly ME; Doumbia SS; Diallo AA; Dembele M; Koudou BG; Bockarie MJ; Kelly-Hope LA; Klion AD; Nutman TB
Parasitol Res; 2022 Nov; 121(11):3243-3248. PubMed ID: 36066741
[TBL] [Abstract][Full Text] [Related]
11. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Six Annual Rounds of Mass Drug Administration on Wuchereria bancrofti Infections in Humans and in Mosquitoes in Mali.
Coulibaly YI; Dembele B; Diallo AA; Konaté S; Dolo H; Coulibaly SY; Doumbia SS; Soumaoro L; Coulibaly ME; Bockarie MJ; Molyneux D; Nutman TB; Klion AD; Toure YT; Traore SF
Am J Trop Med Hyg; 2015 Aug; 93(2):356-60. PubMed ID: 26033027
[TBL] [Abstract][Full Text] [Related]
13. Integrated seroprevalence-based assessment of Wuchereria bancrofti and Onchocerca volvulus in two lymphatic filariasis evaluation units of Mali with the SD Bioline Onchocerciasis/LF IgG4 Rapid Test.
Dolo H; Coulibaly YI; Dembele B; Guindo B; Coulibaly SY; Dicko I; Doumbia SS; Dembele M; Traore MO; Goita S; Dolo M; Soumaoro L; Coulibaly ME; Diallo AA; Diarra D; Zhang Y; Colebunders R; Nutman TB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007064. PubMed ID: 30699120
[TBL] [Abstract][Full Text] [Related]
14. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas.
Shiferaw W; Kebede T; Graves PM; Golasa L; Gebre T; Mosher AW; Tadesse A; Sime H; Lambiyo T; Panicker KN; Richards FO; Hailu A
Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):117-27. PubMed ID: 22154976
[TBL] [Abstract][Full Text] [Related]
16. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
[TBL] [Abstract][Full Text] [Related]
17. Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
Bah YM; Paye J; Bah MS; Conteh A; Redwood-Sawyerr V; Sonnie M; Veinoglou A; Koroma JB; Hodges MH; Zhang Y
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008877. PubMed ID: 33370270
[TBL] [Abstract][Full Text] [Related]
18. Status of lymphatic filariasis with progression of age and gender & eradication strategies: A survey among residents of Hardoi district of Uttar Pradesh, an endemic region of North India.
Saeed M; Faisal SM; Ahmad I; Kausar MA; Alam MJ; Khan S; Mustafa H
Cell Mol Biol (Noisy-le-grand); 2018 Mar; 64(4):46-51. PubMed ID: 29642988
[TBL] [Abstract][Full Text] [Related]
19. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
20. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
